The risk premium on all Biotechs has just been cranked up a few notches. Especially for those trying to build their presence in the US funded through a CR. This is going to take sometime to settle down. We need more info on what Trump is planning exactly and it would be good to have an update on Sofdra sales.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.3¢ |
Change
0.023(7.76%) |
Mkt cap ! $598.0M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 32.5¢ | 29.5¢ | $3.102M | 10.01M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 182717 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 238232 | 11 |
View Market Depth
| Last trade - 15.34pm 26/06/2025 (20 minute delay) ? |
| BOT (ASX) Chart |